Vuzix Corporation — Q3 2023 Form 10-Q
Reporting period: Three and nine months ended September 30, 2023. Unaudited consolidated financial statements; comparisons are with the corresponding 2022 periods. Vuzix designs and sells wearable computing and augmented-reality display products and provides engineering services.
Financial performance
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $2.18 million | $3.43 million | $11.06 million | $8.94 million |
| Gross profit (loss) | $(0.24) million | $0.87 million | $1.61 million | $1.61 million |
| Gross margin | (11)% | 25% | 15% | 18% |
| Operating loss | $(11.43) million | $(9.97) million | $(31.89) million | $(30.38) million |
| Net loss | $(10.98) million | $(9.48) million | $(30.27) million | $(30.00) million |
| Loss per share, basic and diluted | $(0.17) | $(0.15) | $(0.48) | $(0.47) |
- Revenue trends: Q3 revenue fell 36%, primarily because product sales declined 46%, including lower smart-glasses revenue and M400 unit sales. Nine-month revenue rose 24%: product sales increased 26%, primarily on higher M400 sales, while engineering-services revenue grew 8%.
- Margins and costs: Q3 moved to a gross loss as revenue declined while cost of sales remained comparatively high; unapplied manufacturing overhead was 15% of sales versus 10% a year earlier. Nine-month gross profit was nearly flat in dollars, but margin declined to 15% from 18%. Q3 operating expenses increased 3%; nine-month expenses increased 5%, with higher selling and marketing and amortization partly offset by lower R&D and G&A.
- Cash flow: Nine-month operating cash use was $20.13 million, versus $17.94 million in 2022. Investing cash use was $13.93 million, including $9.50 million of Atomistic license payments and $3.61 million for equipment and facility improvements. Financing cash use was $0.45 million. Cash declined by $34.51 million to $38.05 million.
- Liquidity and debt: Current assets were $59.61 million and current liabilities $5.14 million, yielding working capital of $54.47 million, down from $75.96 million at year-end 2022. The company reported no debt obligations; current licensing commitments of $2.00 million and operating lease liabilities remain.
- Other balance-sheet measures: Total assets were $100.99 million and stockholders’ equity $95.68 million. Inventory was $11.30 million, including a $1.90 million obsolescence reserve. Accounts receivable rose to $6.95 million from $3.56 million at year-end.
Material changes and notable items
- Q3 sales deterioration contrasted with nine-month growth, highlighting uneven quarterly demand. Management attributed the Q3 product decline mainly to lower M400 unit sales and a lack of smart-glasses revenue.
- Nine-month product cost of sales rose 31%, faster than product revenue growth; management cited a Q1 supply-chain issue that slowed production and increased unapplied manufacturing overhead in dollars.
- Technology-license amortization, primarily relating to the Atomistic agreements, contributed to higher depreciation and amortization expense. The company had a remaining $2.00 million Atomistic license funding commitment as of September 30, expected to be paid over the following three months.
- Subject to Atomistic deliverables and milestones, Vuzix also committed to pay $2.50 million and issue between 1,750,000 and 2,874,754 shares, depending on its share price within the stated range. Expected share issuance was over the following three to fifteen months.
- Stock-based compensation was $9.80 million for the first nine months. The filing says up to an additional $34.1 million of non-cash LTIP expense could be recognized if currently not-probable operational milestones become probable or are achieved.
Outlook, risks and contingencies
- The filing gives no specific revenue, earnings, margin, or cash-flow guidance. Management identifies cash sufficiency for at least the next 12 months as a forward-looking matter, but does not provide a quantified runway estimate in the presented text.
- Management describes markets subject to rapid technological change, competition, product-acceptance uncertainty, customer order volatility, dependence on a limited number of customers and suppliers, and manufacturing-capacity and inventory risks. Economic uncertainty may delay customer orders; a substantial portion of revenue may come from orders placed and shipped within the same quarter.
- Customer concentration is significant: in Q3, one customer represented 21% of product revenue, while three customers represented 54%, 18%, and 14% of engineering-services revenue. At quarter-end, two customers represented 54% and 22% of accounts receivable.
- Other cited exposures include foreign-currency movements, which Vuzix does not hedge, and potential impairment of investments. No material litigation was reported; the filing states no material changes to the risk factors in the 2022 Form 10-K.
- Management reported disclosure controls were effective as of September 30, 2023, and no material change in internal control over financial reporting during the quarter.
Key facts for investors to verify
- Whether product demand and M400 sales recover after Q3’s 46% year-over-year product-revenue decline, and how customer order timing affects quarterly results.
- Whether gross margins improve, given Q3’s gross loss and nine-month margin decline, and whether manufacturing utilization and supply constraints normalize.
- Cash burn and liquidity: operating cash use accelerated versus the prior-year period while cash fell to $38.05 million; monitor the pace of spending and remaining investment commitments.
- Completion, timing, and financial impact of the Atomistic deliverables, cash payments, and potential share issuance; also assess the possible additional LTIP compensation expense.
- Customer concentration and receivable collectability, including the two customers representing 76% of accounts receivable at quarter-end.